This type of therapy has promise, however, as it allows for the autologous transplantation of the patients own healthy stem cells rather than requiring an outside donor, thereby bypassing any potential for graft vs. host disease (GVHD).In the United States, the FDA approved clinical trials on Beta thalassemia patients in 2012. The first study, which took place in July 2012, recruited human subjects with thalassemia major,

See also
Thalassemia
Hemoglobinopathy
List of hematologic conditions

References
Further reading
Greer, John P.; Arber, Daniel A.; Glader, Bertil; List, Alan F.; Means, Robert T.; Paraskevas, Frixos; Rodgers, George M. (2013-08-29). Wintrobes Clinical Hematology. Lippincott Williams & Wilkins. ISBN 9781469846224. Iolascon, Achille; Delaunay, Jean; Wickramasinghe, Sunitha N.; Perrotta, Silverio; Gigante, Maddalena; Camaschella, Clara (2001-08-15). "Natural history of congenital dyserythropoietic anemia type II". Blood. 98 (4): 1258–1260. doi:10.1182/blood.V98.4.1258. ISSN 0006-4971. PMID 11493480. == External links ==
Unasyn is the trade name for two related antibiotic drugs:

Ampicillin/sulbactam, a fixed-dose combination medication of the penicillin antibiotic combination ampicillin/sulbactam
Sultamicillin, an oral form of the penicillin antibiotic combination ampicillin/sulbactam